Abstract
Controversy still exists about uric acid as a potential prognosticrisk factor for outcomes in patients with acute myocardial infarction. We prospectively assessed, in 856 patients with ST-elevation myocardial infarction (STMI) consecutively admitted to our Intensive Cardiac Care Unit after primary percutaneous coronary intervention (PCI) whether uric acid (UA) levels are associated with in-hospital mortality and complications. Killip classes III-–IV were more frequent in the 3° UA tertile that was associated with the highest values of peak Tn I (p = 0.005), NT-proBNP (p < 0.001), and fibrinogen (p = 0.036). Uric acid was associated with mortality (crude OR: 1.24; 95% CI 1.03–1.51; p = 0.025), but, when adjusted for Tn I and renal failure (as inferred by eGFR <60 ml/min/1.73 m2), uric acid lost its statistical significance, while Tn I (100 pg/ml step OR: 1.002; 95% CI 1.000–1.003; p = 0.007) and renal failure (OR 9.16; 95% CI 3.60–23.32; p < 0.001) were independent predictors for in-ICCU mortality. Uric acid remained as independent predictor for in-ICCU complications (1 mg/dl step OR: 1.11; 95% CI 1.01–1.21; p = 0.030) together with admission glycemia (1 g/dl step OR: 1.50; 95% CI 1.19–1.91; p < 0.001) and renal failure (OR: 1.46; 95% CI 0.99–2.16; p < 0.001). In STEMI patients submitted to PCI, increased uric acid levels identify a subgroup more prone to in-ICCU complications, probably because hyperuricemia stems from several complex mechanisms ranging from pre-existing risk factors to the degree of myocardial ischemia (as indicated by Killip class, ejection fraction) and to the acute metabolic response (as inferred by glucose levels). Hyperuricemia is not independently associated with early mortality when adjusted for renal function and the degree of myocardial damage.
Similar content being viewed by others
References
Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811–1821
Vitart V, Rudan I, Hayward C, Gray NK, Floyd J et al (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40:437–442
Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J et al (2003) Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183–1190
Kang D (2010) Potential role of uric acid as a risk factor for cardiovascular disease. Korean J Internal Med 25:18–20
Gagliardi AC, Miname MH, Santos RD (2009) Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 202(1):11–17
Strazzullo P, Puig JG (2007) Uric acid and oxidative stress: relative impact on cardiovascular risk? Nutr Metab Cardiovasc Dis 17(6):409–414
Lehto S, Niskanen L, Rönnemaa T, Laakso M (1998) Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 29(3):635–639
Weir CJ, Muir SW, Walters MR, Lees KR (2003) Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 34(8):1951–1956
Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D et al (2003) Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107(15):1991–1997
Bickel C, Rupprecht HJ, Blankenberg S, Rippin G, Hafner G et al (2002) Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. Am J Cardiol 89(1):12–17
Nadkar MY, Jain VI (2008) Serum uric acid in acute myocardial infarction. J Assoc Physicians India 56:759–762
Homayounfar S, Ansari M, Kashani KM (2007) Evaluation of independent prognostic importance of hyperuricemia in hospital death after acute myocardial infarction. Saudi Med J 28(5):759–761
Kojima S, Sakamoto T, Ishihara M, Kimura K, Miyazaki S et al (2005) Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 96:489–495
Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF (2010) Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers A single center experience. Int J Cardiol 138:206–216
Celik T, Iyisoy A (2009) Uric acid levels for the prediction of prognosis in patients with acute ST elevation myocardial infarction: a new potential biomarker. In J Cardiol. doi:10.1016/j.ijcard.2008.12.073
Valente S, Lazzeri C, Chiostri M, Giglioli C, Sori A et al (2009) NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 132(1):84–89
Thygesen K, Alpert JS, White HD (2007) Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur Heart J 28(20):2525–2538
Lazzeri C, Valente S, Tarquini R, Chiostri M, Picariello C, Gensini GF (2010) The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction. Int Emerg Med (Epub ahead of print)
Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Predictors of the early outcome in elderly patients with ST elevation myocardial infarction treated with primary angioplasty: a single center experience. Int Emerg Med (Epub ahead of print)
Lazzeri C, Valente S, Chiostri M, Picariello C and Gensini GF (2010) In hospital peak glycemia and prognosis in STEMI patients without previously known diabetes. Eur J Card Prev Rehab (in press)
Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) Acid-base imbalance in uncomplicated ST-elevation myocardial infarction: the clinical role of tissue acidosis. Int Emerg Med 5(1):61–66
Ward HJ (1998) Uric acid as an independent risk factor in the treatment of hypertension. Lancet 352(9129):670–671
Kanellis J, Watanabe S, Li JH, Kang DH, Li P et al (2003) Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41(6):1287–1293
Ferroni P, Basili S, Paoletti V, Davì G (2006) Endothelial dysfunction and oxidative stress in arterial hypertension. Nutr Metab Cardiovasc Dis 16(3):222–233
Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA (2005) Uric acid and oxidative stress. Curr Pharm Des 11(32):4145–4151
Zweier JL, Kuppusamy P, Lutty GA (1988) Measurement of endothelial cell free radical generation: evidence for a central mechanisms of free radical injury in post ischemic tissue. Proc Natl Acad Sci 85:4046–4050
Khosla UM, Zharikov S, Finch JL et al (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67:1739–1742
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s11739-016-1556-x.
Rights and permissions
About this article
Cite this article
Lazzeri, C., Valente, S., Chiostri, M. et al. Uric acid in the early risk stratification of ST-elevation myocardial infarction. Intern Emerg Med 7, 33–39 (2012). https://doi.org/10.1007/s11739-011-0515-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-011-0515-9